Hemophilia A Global Clinical Trials Review, H2, 2016

Date: August 31, 2016
Pages: 228
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H5185F25DFEEN
Leaflet:

Download PDF Leaflet

Hemophilia A Global Clinical Trials Review, H2, 2016

SUMMARY

GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, H2, 2016' provides an overview of Hemophilia A clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hemophilia A Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hemophilia A
Jul 27, 2016: CSL Behring Presents Pivotal Efficacy Data for AFSTYLA In Adolescents and Children with Hemophilia A at the World Federation of Hemophilia 2016 World Congress
Jul 26, 2016: Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A
Jul 26, 2016: ADYNOVATE Phase 3 Efficacy and Safety Data in Children to be Showcased During International Congress of the World Federation of Hemophilia
Jul 26, 2016: SIPPET Study was WFH 2016 World Congress Highlight
Jul 25, 2016: Alnylam Announces New Positive Interim Phase 1 Study Results for Fitusiran, a Once-Monthly, Subcutaneous, Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia and Rare Bleeding Disorders
Jul 25, 2016: Alnylam to Report New Clinical Results with Fitusiran at the World Federation of Hemophilia 2016 World Congress
Jul 19, 2016: CSL Behring to Present New Data for AFSTYLA at the World Federation of Hemophilia 2016 World Congress
Jul 19, 2016: Shire reinforces commitment in Hematology with robust data presented at international congress of the World Federation of Hemophilia
Jul 18, 2016: Biogen and Sobi to Showcase Long-Term Efficacy and Safety Data on ELOCTATE at World Federation of Hemophilia 2016 World Congress
Jul 18, 2016: Biogen and Sobi to Showcase Data on FVIIIFc-VWF-XTEN at World Federation of Hemophilia 2016 World Congress
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hemophilia A Therapeutics, Global, Clinical Trials by Region, 2016
Hemophilia A Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016
Hemophilia A Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016
Hemophilia A Therapeutics Clinical Trials, Europe, Top Five Countries, 2016
Hemophilia A Therapeutics Clinical Trials, North America, Top Countries, 2016
Hemophilia A Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016
Hemophilia A Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, G7 Countries (%), 2016
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Phase, 2016
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, E7 Countries (%), 2016
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Phase, 2016
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016
Hemophilia A Therapeutics, Global, Clinical Trials by Phase, 2016
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Phase 2016
Hemophilia A Therapeutics, Global, Clinical Trials by Trial Status, 2016
Hemophilia A Therapeutics Clinical Trials, Global, by End Point Status, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Hemophilia A Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Key Sponsors, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016

LIST OF FIGURES

Hemophilia A Therapeutics, Global, Clinical Trials by Region (%), 2016
Hemophilia A Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016
Hemophilia A Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016
Hemophilia A Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016
Hemophilia A Therapeutics Clinical Trials, North America, Top Countries (%), 2016
Hemophilia A Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016
Hemophilia A Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, G7 Countries (%), 2016
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Phase, 2016
Hemophilia A Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016
Proportion of Hemophilia A to Hematological Disorders Clinical Trials, E7 Countries (%), 2016
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Phase, 2016
Hemophilia A Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016
Hemophilia A Therapeutics, Global, Clinical Trials by Phase (%), 2016
Hemophilia A Therapeutics, Global, Clinical Trials In Progress by Phase, 2016
Hemophilia A Therapeutics, Global, Clinical Trials by Trial Status, 2016
Hemophilia A Therapeutics Clinical Trials, Global, by End Point Status, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
Hemophilia A Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016
Hemophilia A Therapeutics Clinical Trials, Global, Key Sponsors, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016
Hemophilia A Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016
GlobalData Methodology

COMPANIES MENTIONED

Novo A/S
Shire Plc
Bayer AG
Pfizer Inc.
Baxter International Inc.
CSL Limited
Octapharma AG
F. Hoffmann-La Roche Ltd.
Biogen Inc
Ministry of Health, France
Skip to top


Hemophilia B Global Clinical Trials Review, H2, 2016 US$ 2,500.00 Aug, 2016 · 129 pages

Ask Your Question

Hemophilia A Global Clinical Trials Review, H2, 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: